Small molecule inhibitors of PTP1B and TCPTP

M. V V V Sekhar Reddy, G. Chakshusmathi, M. Lakshmi Narasu

Research output: Contribution to journalArticle

Abstract

Fragment based drug design is a new approach in identifying the initial chemical starting point for drug discovery programs. Fragment based drug design allows screening of substantially fewer compounds usually hundred - thousand compounds. It identifies fragments which bind specifically but with low affinity in the range of 0.1-10mM. The small sized fragments make the subsequent optimization relatively easier to build the molecule by exploring the chemical space in the binding pocket. The virtual screening study of small molecule compounds from a chemical library was carried out and few molecules were selected as inhibitors of PTP1B/TCPTP. These molecules were tested by in-vitro biochemical assay and were inhibiting both PTP1B and TCPTP. One of the compounds AU-008 was found selective to PTP1B over TCPTP by 3 fold.

Original languageEnglish (US)
Pages (from-to)158-161
Number of pages4
JournalResearch Journal of Biotechnology
Volume7
Issue number4
StatePublished - Nov 2012
Externally publishedYes

Fingerprint

Drug Design
Small Molecule Libraries
Molecules
Drug Discovery
Screening
Pharmaceutical Preparations
Assays
In Vitro Techniques
cyclosomatostatin

Keywords

  • FBDD: Fragment based drug discovery
  • PNPP: Para nitro phenol pyrophosphate
  • PTP1B: Protein tyrosine phosphatase
  • TCPTP: T-cell PTP

ASJC Scopus subject areas

  • Biotechnology
  • Applied Microbiology and Biotechnology
  • Bioengineering

Cite this

Sekhar Reddy, M. V. V. V., Chakshusmathi, G., & Lakshmi Narasu, M. (2012). Small molecule inhibitors of PTP1B and TCPTP. Research Journal of Biotechnology, 7(4), 158-161.

Small molecule inhibitors of PTP1B and TCPTP. / Sekhar Reddy, M. V V V; Chakshusmathi, G.; Lakshmi Narasu, M.

In: Research Journal of Biotechnology, Vol. 7, No. 4, 11.2012, p. 158-161.

Research output: Contribution to journalArticle

Sekhar Reddy, MVVV, Chakshusmathi, G & Lakshmi Narasu, M 2012, 'Small molecule inhibitors of PTP1B and TCPTP', Research Journal of Biotechnology, vol. 7, no. 4, pp. 158-161.
Sekhar Reddy MVVV, Chakshusmathi G, Lakshmi Narasu M. Small molecule inhibitors of PTP1B and TCPTP. Research Journal of Biotechnology. 2012 Nov;7(4):158-161.
Sekhar Reddy, M. V V V ; Chakshusmathi, G. ; Lakshmi Narasu, M. / Small molecule inhibitors of PTP1B and TCPTP. In: Research Journal of Biotechnology. 2012 ; Vol. 7, No. 4. pp. 158-161.
@article{c8b81dba1389478d875d7e3cf22f5f7c,
title = "Small molecule inhibitors of PTP1B and TCPTP",
abstract = "Fragment based drug design is a new approach in identifying the initial chemical starting point for drug discovery programs. Fragment based drug design allows screening of substantially fewer compounds usually hundred - thousand compounds. It identifies fragments which bind specifically but with low affinity in the range of 0.1-10mM. The small sized fragments make the subsequent optimization relatively easier to build the molecule by exploring the chemical space in the binding pocket. The virtual screening study of small molecule compounds from a chemical library was carried out and few molecules were selected as inhibitors of PTP1B/TCPTP. These molecules were tested by in-vitro biochemical assay and were inhibiting both PTP1B and TCPTP. One of the compounds AU-008 was found selective to PTP1B over TCPTP by 3 fold.",
keywords = "FBDD: Fragment based drug discovery, PNPP: Para nitro phenol pyrophosphate, PTP1B: Protein tyrosine phosphatase, TCPTP: T-cell PTP",
author = "{Sekhar Reddy}, {M. V V V} and G. Chakshusmathi and {Lakshmi Narasu}, M.",
year = "2012",
month = "11",
language = "English (US)",
volume = "7",
pages = "158--161",
journal = "Research Journal of Biotechnology",
issn = "0973-6263",
publisher = "Research Journal of BioTechnology",
number = "4",

}

TY - JOUR

T1 - Small molecule inhibitors of PTP1B and TCPTP

AU - Sekhar Reddy, M. V V V

AU - Chakshusmathi, G.

AU - Lakshmi Narasu, M.

PY - 2012/11

Y1 - 2012/11

N2 - Fragment based drug design is a new approach in identifying the initial chemical starting point for drug discovery programs. Fragment based drug design allows screening of substantially fewer compounds usually hundred - thousand compounds. It identifies fragments which bind specifically but with low affinity in the range of 0.1-10mM. The small sized fragments make the subsequent optimization relatively easier to build the molecule by exploring the chemical space in the binding pocket. The virtual screening study of small molecule compounds from a chemical library was carried out and few molecules were selected as inhibitors of PTP1B/TCPTP. These molecules were tested by in-vitro biochemical assay and were inhibiting both PTP1B and TCPTP. One of the compounds AU-008 was found selective to PTP1B over TCPTP by 3 fold.

AB - Fragment based drug design is a new approach in identifying the initial chemical starting point for drug discovery programs. Fragment based drug design allows screening of substantially fewer compounds usually hundred - thousand compounds. It identifies fragments which bind specifically but with low affinity in the range of 0.1-10mM. The small sized fragments make the subsequent optimization relatively easier to build the molecule by exploring the chemical space in the binding pocket. The virtual screening study of small molecule compounds from a chemical library was carried out and few molecules were selected as inhibitors of PTP1B/TCPTP. These molecules were tested by in-vitro biochemical assay and were inhibiting both PTP1B and TCPTP. One of the compounds AU-008 was found selective to PTP1B over TCPTP by 3 fold.

KW - FBDD: Fragment based drug discovery

KW - PNPP: Para nitro phenol pyrophosphate

KW - PTP1B: Protein tyrosine phosphatase

KW - TCPTP: T-cell PTP

UR - http://www.scopus.com/inward/record.url?scp=84872065888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872065888&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 158

EP - 161

JO - Research Journal of Biotechnology

JF - Research Journal of Biotechnology

SN - 0973-6263

IS - 4

ER -